Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Indonesia Prima Property Tbk (OMRE)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Indonesia Prima Property Tbk: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,8 rb), sedangkan Indonesia Prima Property Tbk diperdagangkan di Rp955 (kapitalisasi pasar 2,89 T, volume 24 jam 5,1 rb). Perbedaan utamanya: Indonesia Prima Property Tbk jauh lebih besar — sekitar 17,6× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (177,8 rb vs 5,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | OMRE | |
|---|---|---|
Kapitalisasi Pasar | 164,65 M | 2,89 T |
Volume | 177,8 rb | 5,1 rb |
Lot | 1,78 rb | 51 |
Perputaran | 42,05 jt | 4,98 jt |
Harga Rata-rata | 236,47 | 977,06 |
Nilai Transaksi | 42,05 jt | 4,98 jt |
Harga Ekuilibrium Indikatif | 242 | — |
Volume Ekuilibrium Indikatif | 500 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Tentang Indonesia Prima Property Tbk
PT Indonesia Prima Property Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on notarial deed No. 31 dated April 23, 1983 of Sastra Kosasih, S.H., notary in Surabaya. PT Ometraco Realty, is a member of the Ometraco Group. The company operates in developing and managing apartments, office properties, hotels and shopping centers.
Selengkapnya di halaman OMRE →
